Your browser doesn't support javascript.
loading
Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand Factor.
Poitier, Bastien; Chocron, Richard; Peronino, Christophe; Philippe, Aurélien; Pya, Yuri; Rivet, Nadia; Richez, Ulysse; Bekbossynova, Mahabbat; Gendron, Nicolas; Grimmé, Marc; Bories, Marie Cécile; Brichet, Julie; Capel, Antoine; Rancic, Jeanne; Vedie, Benoit; Roussel, Jean Christian; Jannot, Anne-Sophie; Jansen, Piet; Carpentier, Alain; Ivak, Peter; Latremouille, Christian; Netuka, Ivan; Smadja, David M.
  • Poitier B; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France (B.P., A.C., C.L.).
  • Chocron R; Cardiac Surgery Department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (B.P., A.C., C.L.).
  • Peronino C; Carmat SAS, Velizy-Villacoublay, France (B.P., U.R., M.G., A.C., P.J.).
  • Philippe A; Université de Paris, PARCC, INSERM, F-75015 Paris, France, Emergency department, AP-HP, Georges Pompidou European Hospital, France (R.C.).
  • Pya Y; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France, Hematology department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (C.P., A.P., N.R., U.R., N.G., J.B., J.R., D.M.S.).
  • Rivet N; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France, Hematology department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (C.P., A.P., N.R., U.R., N.G., J.B., J.R., D.M.S.).
  • Richez U; National Research Cardiac, Surgery Center, Nur-Sultan, Kazakhstan (Y.P., M.B.).
  • Bekbossynova M; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France, Hematology department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (C.P., A.P., N.R., U.R., N.G., J.B., J.R., D.M.S.).
  • Gendron N; Carmat SAS, Velizy-Villacoublay, France (B.P., U.R., M.G., A.C., P.J.).
  • Grimmé M; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France, Hematology department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (C.P., A.P., N.R., U.R., N.G., J.B., J.R., D.M.S.).
  • Bories MC; National Research Cardiac, Surgery Center, Nur-Sultan, Kazakhstan (Y.P., M.B.).
  • Brichet J; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France, Hematology department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (C.P., A.P., N.R., U.R., N.G., J.B., J.R., D.M.S.).
  • Capel A; Carmat SAS, Velizy-Villacoublay, France (B.P., U.R., M.G., A.C., P.J.).
  • Rancic J; Université de Paris, Cardiac Surgery Department, AP-HP, Georges Pompidou European Hospital, France (M.C.B.).
  • Vedie B; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France, Hematology department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (C.P., A.P., N.R., U.R., N.G., J.B., J.R., D.M.S.).
  • Roussel JC; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France (B.P., A.C., C.L.).
  • Jannot AS; Cardiac Surgery Department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (B.P., A.C., C.L.).
  • Jansen P; Université de Paris, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France, Hematology department and Biosurgical Research lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, France (C.P., A.P., N.R., U.R., N.G., J.B., J.R., D.M.S.).
  • Carpentier A; AP-HP, Biochemistry Department, Georges Pompidou European Hospital, France (B.V.).
  • Ivak P; Cardiac and thoracic Surgery Department, CHU de Nantes, hôpital Nord Laënnec, boulevard Jacques-Monod, France (J.C.R.).
  • Latremouille C; Department of Bioinformatics, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France (A.-S.J.).
  • Smadja DM; Carmat SAS, Velizy-Villacoublay, France (B.P., U.R., M.G., A.C., P.J.).
Arterioscler Thromb Vasc Biol ; 42(4): 470-480, 2022 04.
Article en En | MEDLINE | ID: mdl-35139659
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades de von Willebrand / Corazón Artificial Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades de von Willebrand / Corazón Artificial Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article